Phillips Andrew John
CIK: 0001921956
Director
Primary company: Enliven Therapeutics, Inc. (ELVN)
Phillips Andrew John is a corporate insider at Enliven Therapeutics, Inc. (ELVN) filing SEC Form 4 transactions. 12 transactions across 3 companies. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 22,195 | $19.19 | $426K | 22,195 | 6/17/2026 Filed: 6/17/2026 | Filing → | |
| Award | 7,650 | $4.30 | $33K | 7,650 | 6/4/2026 Filed: 6/4/2026 | Filing → | |
| Award | 6,682 | - | - | 6,682 | 6/5/2025 Filed: 6/9/2025 | Filing → | |
| Award | 7,650 | - | - | 7,650 | 5/28/2025 Filed: 5/30/2025 | Filing → | |
| Award | 20,491 | $22.47 | $460K | 20,491 | 2/6/2025 Filed: 2/10/2025 | Filing → | |
| Award | 15,300 | - | - | 15,300 | 10/4/2024 Filed: 10/8/2024 | Filing → | |
| Award | 7,688 | - | - | 7,688 | 6/6/2024 Filed: 6/7/2024 | Filing → | |
| Award | 23,364 | - | - | 23,364 | 2/13/2024 Filed: 2/20/2024 | Filing → | |
| Award | 16,835 | - | - | 16,835 | 2/13/2024 Filed: 2/15/2024 | Filing → | |
| Award | 11,297 | $0.00 | $0 | 11,297 | 6/8/2023 Filed: 6/12/2023 | Filing → | |
| Award | 27,567 | $0.00 | $0 | 27,567 | 2/23/2023 Filed: 4/6/2023 | Filing → | |
| Award | 45,000 | $0.00 | $0 | 45,000 | 4/6/2022 Filed: 5/5/2022 | Filing → |
Type
Award
Shares
22,195
Price
$19.19
Value
$426K
Type
Award
Shares
7,650
Price
$4.30
Value
$33K
Type
Award
Shares
6,682
Price
-
Value
-
Type
Award
Shares
7,650
Price
-
Value
-
Type
Award
Shares
20,491
Price
$22.47
Value
$460K
Type
Award
Shares
15,300
Price
-
Value
-
Type
Award
Shares
7,688
Price
-
Value
-
Type
Award
Shares
23,364
Price
-
Value
-
Type
Award
Shares
16,835
Price
-
Value
-
Type
Award
Shares
11,297
Price
$0.00
Value
$0
Type
Award
Shares
27,567
Price
$0.00
Value
$0
Type
Award
Shares
45,000
Price
$0.00
Value
$0
AI Agent
Try asking...